Pfizer Norvasc 5mg

Norvasc is a widely recognized prescription medication used primarily to treat high blood pressure and chest pain (angina). It contains the active ingredient amlodipine besylate, which belongs to a class of drugs known as calcium channel blockers. The brand was originally developed and launched by the American pharmaceutical giant Pfizer.

Historically, Norvasc has been manufactured in various global facilities to serve international markets, including major production sites in the United States, Ireland, and Germany. While the brand carries the legacy and reputation of Pfizer, the landscape of its ownership underwent a significant change in recent years. In 2020, Pfizer spun off its Upjohn division—which included established off-patent brands like Norvasc—and merged it with the company Mylan to create a new, independent global healthcare entity named Viatris.

Today, Viatris is the ultimate owner of the Norvasc brand. Headquartered in the United States, Viatris continues to manage the production and distribution of Norvasc across the globe, maintaining the quality standards established during Pfizer's initial stewardship. Depending on the region, local distribution may still involve Pfizer subsidiaries under transitional agreements or Viatris-specific entities.